MDM2 analysis in the management of benign lipomas versus atypical lipomatous tumors/well-differentiated liposarcomas: A useful prognostication tool?


      • With upfront marginal resection of truncal or extremities atypical lipomatous tumors/well-differentiated liposarcomas, overall local recurrence rate of 1.4% and reoperation rate of 1.1% were achieved.
      • When tumors showed MDM2 amplification, local recurrence rate of 6.1% was found as opposed to 0.8% in tumors with no MDM2 amplification.
      • There was no dedifferentiation or metastasis found with local recurrence.



      Well-differentiated liposarcomas (WDLS) are low-grade lipomatous tumors with low malignant potential. Previous review identified controversy on whether upfront wide resection is necessary when they occur on the trunk or the extremities. MDM2 amplification is a genetic mutation typically present in WDLS and absent in benign lipomas (BL). We aimed to study the influence of MDM2 status on the management/recurrences of lipomatous tumors in the trunk or the extremities.


      All patients with lipomatous tumors with MDM2 testing in the Province of Alberta between 2015 and 2020 were identified from the Cancer Cytogenetics Laboratory dataset. High grade sarcomas, retroperitoneal, head/neck, or groin tumors were excluded. Primary outcome measures including MDM2 status, surgical margin, local recurrence, reoperation rate, dedifferentiation, and metastasis were abstracted from chart review. Descriptive statistics were used to analyse treatment patterns and recurrence rates according to MDM2 status.


      Total of 764 charts were retrieved, and 282 were included for analysis. 33 showed MDM2 amplification (11.7%), and 2 of them had local recurrence (6.1%). Two patients with recurrent tumors underwent limb-salvaging reoperation (6.1%), but no dedifferentiation or metastasis was seen.


      Findings in this study confirmed the benign behaviour of truncal/extremities lipomas with no MDM2 amplification. Given we found a 6.1% recurrence rate in MDM2 amplified tumors, a prolong follow up of this subset of patients is warranted. Overall, regardless of the MDM2 status, we believe an initial marginal excision is a reasonable surgical approach as recurrences are rare, and they can be managed with re-excision when they occur.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Dei Tos A.
        • Pedeutour F.
        • Marino-Enriquez A.
        • et al.
        WHO classification of tumours of soft tissue and bone.
        in: WHO Classification of Tumours. fourth ed. IARC, Lyon2013: 38-39
        • Evans H.L.
        Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years.
        Am J Surg Pathol. 2007; 31: 1-14
        • Kooby D.A.
        • Antonescu C.R.
        • Brennan M.F.
        • Singer S.
        Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations.
        Ann Surg Oncol. 2004; 11: 78-84
        • Rozental T.D.
        • Khoury L.D.
        • Donthineni-Rao R.
        • Lackman R.D.
        Atypical lipomatous masses of the extremities: outcome of surgical treatment.
        Clin Orthop Relat Res. 2002; 398: 203-211
        • Evans H.L.
        • Soule E.H.
        • Winkelmann R.K.
        Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma: a reappraisal of 30 cases formerly classified as well differentiated liposarcoma.
        Cancer. 1979; 43: 574-584
        • Fletcher C.D.
        Soft tissue tumors.
        in: Fletcher C.D. Diagnostic Histopathology of Tumors. second ed. Harcourt Publishers Limited, London2000: 1473-1540
        • Kindblom L.G.A.L.
        • Fassina A.S.
        Atypical lipoma.
        Acta Pathol Microbiol Immunol Scand [A]. 1982; 90: 27-36
        • Choi K.Y.
        • Jost E.
        • Mack L.
        • Bouchard-Fortier A.
        Surgical management of truncal and extremities atypical lipomatous tumors/well-differentiated liposarcoma: a systematic review of the literature.
        Am J Surg. 2020; 219: 823-827
        • Bassett M.D.
        • Schuetze S.M.
        • Disteche C.
        • et al.
        Deep-seated, well differentiated lipomatous tumors of the chest wall and extremities: the role of cytogenetics in classification and prognostication.
        Cancer. 2005; 103: 409-416
        • Dei Tos A.P.P.F.
        Atypical lipomatous tumor.
        in: Fletcher C.D.M. Bridge J.A. Hogendoorn P.C.W. Mertens F. WHO Classification of Tumors of Soft Tissue and Bone. fourth ed.s. IARC Press, Lyon2013: 33-36
        • Kubo T.
        • Sugita T.
        • Shimose S.
        • Arihiro K.
        • Ochi M.
        Conservative surgery for well-differentiated liposarcomas of the extremities adjacent to major neurovascular structures.
        Surg Oncol. 2006; 15: 167-171
        • Lucas D.R.
        • Nascimento A.G.
        • Sanjay B.K.
        • Rock M.G.
        Well-differentiated liposarcoma. The Mayo Clinic experience with 58 cases.
        Am J Clin Pathol. 1994; 102: 677-683
        • Fisher S.B.
        • Baxter K.J.
        • Staley 3rd, C.A.
        • et al.
        The General Surgeon's quandary: atypical lipomatous tumor vs lipoma, who needs a surgical oncologist?.
        J Am Coll Surg. 2013; 217: 881-888
        • Billing V.
        • Mertens F.
        • Domanski H.A.
        • Rydholm A.
        Deep-seated ordinary and atypical lipomas: histopathology, cytogenetics, clinical features, and outcome in 215 tumours of the extremity and trunk wall.
        J Bone Joint Surg Br. 2008; 90: 929-933
        • Oliner J.D.
        • Saiki A.Y.
        • Caenepeel S.
        The role of MDM2 amplification and overexpression in tumorigenesis.
        Cold Spring Harb Perspect Med. 2016; 6
        • Binh M.B.S.-G.X.
        • Guillou L.
        • et al.
        MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
        Am J Surg Pathol. 2005; 29: 1340-1347
        • Shimada S.
        • Ishizawa T.
        • Ishizawa K.
        • Matsumura T.
        • Hasegawa T.
        • Hirose T.
        The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
        Hum Pathol. 2006; 37: 1123-1129
        • Weaver J.
        • Rao P.
        • Goldblum J.R.
        • et al.
        Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma?.
        Mod Pathol. 2010; 23: 1301-1306
        • Binh M.B.
        • Sastre-Garau X.
        • Guillou L.
        • et al.
        MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
        Am J Surg Pathol. 2005; 29: 1340-1347
        • Mussi C.E.
        • Daolio P.
        • Cimino M.
        • et al.
        Atypical lipomatous tumors: should they be treated like other sarcoma or not? Surgical consideration from a bi-institutional experience.
        Ann Surg Oncol. 2014; 21: 4090-4097
        • Errani C.
        • Cocchi S.
        • Ali N.
        • et al.
        Recurrence after marginal excision for atypical lipomatous tumors versus lipomas of the extremities.
        Orthopedics. 2016; 39: e610-e614
        • Kito M.
        • Yoshimura Y.
        • Isobe K.
        • et al.
        Clinical outcome of deep-seated atypical lipomatous tumor of the extremities with median-term follow-up study.
        Eur J Surg Oncol. 2015; 41: 400-406